The Law Offices of Sheryl Gandel Mazur Se habla espanol
  • Toll Free 877-892-0197
  • North New Jersey 973-200-6629
  • South New Jersey 609-207-7905
Related Areas

Researchers identify molecular marker to predict breast cancer

Unlike some other forms of cancer, a breast cancer diagnosis isn't always a death sentence - treatment and eventual survival are probable. But when the diagnosis is for stage IV breast cancer, also referred to as metastatic breast cancer, the prognosis is typically far more bleak, which is also why this form of the disease appears on the Social Security Administration's Compassionate Allowances list.

Though regular screening and a thorough look at a patient's family history can indicate a woman's risk of developing breast cancer, it hasn't always been enough to catch the disease or even asses a woman's risk of developing the disease. That is until now.

Researchers from Harvard University believe they may have come up with a way of detecting a woman's risk of developing breast cancer. Researchers can do this by looking for a specific molecular marker known as Ki67 in a woman's breast tissue. According to the research team's recent findings, by looking for this marker, they were more likely to predict development of breast cancer in patients.

Because stage IV breast cancer can develop out of earlier stages of breast cancer and because of its high mortality rate, tests like the one Harvard researchers recently developed gives women everywhere hope for the future. Not only could this test indicate a woman's risk of developing the disease down the road, it will also be able to tell them how high that risk is. This will give many women the ability to make more educated decisions about their conditions, such as which treatments to undertake and whether applying for disability benefits will be a necessity down the road.

Sources: The Economic Times, "Now, breast cancer can be predicted by molecular marker," April 8, 2016

The Susan G. Komen Foundation, "Metastatic Breast Cancer," Accessed April 8, 2016

The Social Security Administration, "DI 23022.125 Breast Cancer," Accessed April 8, 2016

No Comments

Leave a comment
Comment Information

Contact Our Firm For A Free Initial Consultation | Se Habla Español

For assistance anywhere in the state, please send an email or call 973-200-6629 (toll free 1-855-200-4118).

Our offices are open weekdays from 9 a.m. to 5 p.m., and we return all calls as promptly as possible.

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

West Caldwell Office
195 Fairfield Avenue
Suite 2C
West Caldwell, NJ 07006

Toll Free: 877-892-0197
Phone: 973-200-6629
Fax: 973-364-1348
Map & Directions

Absecon Office
508 New Jersey Ave
Building B
Suite 1B
Absecon, NJ 08201

Toll Free: 877-892-0197
Phone: 609-207-7905
Map & Directions

  • Toll Free: 877-892-0197
  • Fax: 973-364-1348
  • Phone: 973-200-6629
  • Toll Free: 877-892-0197
  • Phone: 609-207-7905